B
BEYONDSPRING INC
NASDAQ: BYSI (BeyondSpring, Inc.)
Last update: 15 hours ago2.12
-0.08 (-3.64%)
| Previous Close | 2.20 |
| Open | 2.07 |
| Volume | 22,823 |
| Avg. Volume (3M) | 38,329 |
| Market Cap | 85,504,512 |
| Price / Sales | 31.22 |
| Price / Book | 5.38 |
| 52 Weeks Range | |
| Earnings Date | 12 Nov 2025 |
| Diluted EPS (TTM) | -0.220 |
| Quarterly Revenue Growth (YOY) | 14.30% |
| Current Ratio (MRQ) | 2.49 |
| Operating Cash Flow (TTM) | -15.37 M |
| Levered Free Cash Flow (TTM) | -12.95 M |
| Return on Assets (TTM) | -18.51% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | BeyondSpring, Inc. | Mixed | Mixed |
AIStockmoo Score
0.5
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 2.0 |
| Average | 0.50 |
|
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 15.26% |
| % Held by Institutions | 14.41% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Decheng Capital Llc | 30 Jun 2025 | 4,531,481 |
| Tanaka Capital Management Inc | 31 Mar 2025 | 26,296 |
| Trifecta Capital Advisors, Llc | 30 Sep 2025 | 1,500 |
| Steward Partners Investment Advisory, Llc | 30 Sep 2025 | 1,080 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Nov 2025 | Announcement | BeyondSpring Reports Third‑Quarter 2025 Financial Results and Provides Corporate Update |
| 13 Aug 2025 | Announcement | BeyondSpring Reports Second‑Quarter 2025 Financial Results and Provides Corporate Update: Accelerates Momentum with Promising Clinical Advances and Strategic Leadership Appointment |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |